Literature DB >> 30381790

Bioactivity-guided isolation and purification of α-glucosidase inhibitor, 6-O-D-glycosides, from Tinta Cão grape pomace.

Shi Sun1, Hoda Chaouki Kadouh1, Wenjun Zhu1, Kequan Zhou1.   

Abstract

Bioactivity-guided fractionation methods were used to identify and purify active components in Tinta Cão grape pomace extract (GPE) that inhibit intestinal α-glucosidases. One active α-glucosidase inhibitor and one new natural product determined as 6-O-(p-coumaroyl)-D-glucopyranoside and methyl 6-O-(p-coumaroyl)-β-D-galactopyranoside, respectively, were isolated from GPE that were previously shown to potently inhibit α-glucosidase. Analysis of the relationship between structures and activity suggested that C1-OH of saccharide moiety in phenolic glycosides is necessary for this potent inhibition of intestinal α-glucosidases for the potential development of a novel anti-hyperglycaemic dietary supplement.

Entities:  

Keywords:  6-O-p-trans-coumaroyl-D-glucopyranoside; Anti-hyperglycaemic agents; Diabetes; Red wine grapes; α-Glucosidase

Year:  2016        PMID: 30381790      PMCID: PMC6205201          DOI: 10.1016/j.jff.2016.03.009

Source DB:  PubMed          Journal:  J Funct Foods        ISSN: 1756-4646            Impact factor:   4.451


  27 in total

1.  Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.

Authors:  Floris A van de Laar; Peter L Lucassen; Reinier P Akkermans; Eloy H van de Lisdonk; Guy E Rutten; Chris van Weel
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

2.  Comparative study of the inhibition of alpha-glucosidase, alpha-amylase, and cyclomaltodextrin glucanosyltransferase by acarbose, isoacarbose, and acarviosine-glucose.

Authors:  M J Kim; S B Lee; H S Lee; S Y Lee; J S Baek; D Kim; T W Moon; J F Robyt; K H Park
Journal:  Arch Biochem Biophys       Date:  1999-11-15       Impact factor: 4.013

3.  alpha-Glucosidase inhibitors prevent diet-induced increases in intestinal sugar transport in diabetic mice.

Authors:  Donatella M Casirola; Ronaldo P Ferraris
Journal:  Metabolism       Date:  2006-06       Impact factor: 8.694

4.  Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.

Authors:  S Yamagishi; K Nakamura; M Takeuchi
Journal:  Med Hypotheses       Date:  2005-01-28       Impact factor: 1.538

5.  Insulin therapy for diabetes mellitus: treatment regimens and associated costs.

Authors:  B Charbonnel; A Penfornis; M Varroud-Vial; O Kusnik-Joinville; B Detournay
Journal:  Diabetes Metab       Date:  2011-12-14       Impact factor: 6.041

6.  Antioxidant rich grape pomace extract suppresses postprandial hyperglycemia in diabetic mice by specifically inhibiting alpha-glucosidase.

Authors:  Shelly Hogan; Lei Zhang; Jianrong Li; Shi Sun; Corene Canning; Kequan Zhou
Journal:  Nutr Metab (Lond)       Date:  2010-08-27       Impact factor: 4.169

7.  Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance.

Authors:  Ryuzo Kawamori; Naoko Tajima; Yasuhiko Iwamoto; Atsunori Kashiwagi; Kazuaki Shimamoto; Kohei Kaku
Journal:  Lancet       Date:  2009-04-22       Impact factor: 79.321

Review 8.  Glycemic index: overview of implications in health and disease.

Authors:  David J A Jenkins; Cyril W C Kendall; Livia S A Augustin; Silvia Franceschi; Maryam Hamidi; Augustine Marchie; Alexandra L Jenkins; Mette Axelsen
Journal:  Am J Clin Nutr       Date:  2002-07       Impact factor: 7.045

9.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

Review 10.  Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Silvio E Inzucchi; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; David R Matthews
Journal:  Diabetes Care       Date:  2012-04-19       Impact factor: 19.112

View more
  5 in total

Review 1.  Tocopherols and Tocotrienols in Common and Emerging Dietary Sources: Occurrence, Applications, and Health Benefits.

Authors:  Fereidoon Shahidi; Adriano Costa de Camargo
Journal:  Int J Mol Sci       Date:  2016-10-20       Impact factor: 5.923

Review 2.  Opinion on the Hurdles and Potential Health Benefits in Value-Added Use of Plant Food Processing By-Products as Sources of Phenolic Compounds.

Authors:  Adriano Costa de Camargo; Andrés R Schwember; Roberto Parada; Sandra Garcia; Mário Roberto Maróstica; Marcelo Franchin; Marisa Aparecida Bismara Regitano-d'Arce; Fereidoon Shahidi
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

3.  α-Glucosidase Inhibitory Activity of Tannat Grape Phenolic Extracts in Relation to Their Ripening Stages.

Authors:  Auriane Dudoit; Nawel Benbouguerra; Tristan Richard; Ruth Hornedo-Ortega; Josep Valls-Fonayet; Gaëlle Coussot; Cédric Saucier
Journal:  Biomolecules       Date:  2020-07-22

4.  Do Flavonoids from Durum Wheat Contribute to Its Bioactive Properties? A Prospective Study.

Authors:  Adriano Costa de Camargo; Anna Paula de Souza Silva; Jackeline Cintra Soares; Severino Matias de Alencar; Cíntia Ladeira Handa; Karina Silva Cordeiro; Marcela Souza Figueira; Geni R Sampaio; Elizabeth A F S Torres; Fereidoon Shahidi; Andrés R Schwember
Journal:  Molecules       Date:  2021-01-17       Impact factor: 4.411

5.  α-Glucosidase Inhibitory Activity of Fermented Okara Broth Started with the Strain Bacillus amyloliquefaciens SY07.

Authors:  Yifang Gao; Wenhui Bian; Yuanyuan Fang; Peng Du; Xueting Liu; Xueru Zhao; Fengjuan Li
Journal:  Molecules       Date:  2022-02-08       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.